mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.077 |
0.1 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.1 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |